Eugenia jambolana extract reduces the systemic exposure of Sitagliptin and improves conditions associated with diabetes: A pharmacokinetic and a pharmacodynamic herb-drug interaction study
Open Access
- 1 October 2019
- journal article
- research article
- Published by Elsevier in Journal of Traditional and Complementary Medicine
- Vol. 9 (4) , 364-371
Abstract
No abstract availableKeywords
Funding Information
- Central Council for Research in Unani Medicines, Ministry of AYUSH, Govt. of India (3.28/2014-CCRUM/Tech)
This publication has 22 references indexed in Scilit:
- Effects of Syzygium aromaticum-Derived Triterpenes on Postprandial Blood Glucose in Streptozotocin-Induced Diabetic Rats Following Carbohydrate ChallengePLOS ONE, 2013
- Antioxidant and Antiproliferative Activities of Anthocyanin/Ellagitannin-Enriched Extracts FromSyzygium cuminiL. (Jamun, the Indian Blackberry)Nutrition and Cancer, 2012
- Identification of bioactive compounds from jambolão (Syzygium cumini) and antioxidant capacity evaluation in different pH conditionsFood Chemistry, 2011
- Safety evaluation of Eugenia jambolana seed extractAsian Pacific Journal of Tropical Medicine, 2010
- Transport of the Dipeptidyl Peptidase-4 Inhibitor Sitagliptin by Human Organic Anion Transporter 3, Organic Anion Transporting Polypeptide 4C1, and Multidrug Resistance P-glycoproteinThe Journal of Pharmacology and Experimental Therapeutics, 2007
- Metabolism And Excretion of the Dipeptidyl Peptidase 4 Inhibitor [14C]Sitagliptin in HumansDrug Metabolism and Disposition, 2007
- Antioxidant activity of phenolic components present in barks of Azadirachta indica, Terminalia arjuna, Acacia nilotica, and Eugenia jambolana Lam. treesFood Chemistry, 2007
- MDR- and CYP3A4-mediated drug–herbal interactionsLife Sciences, 2006
- Herbal Modulation of P‐GlycoproteinDrug Metabolism Reviews, 2004
- St John's Wort increases expression of P‐glycoprotein: Implications for drug interactionsBritish Journal of Clinical Pharmacology, 2002